EMA’s CHMP begins rolling review of molnupiravir to treat Covid-19 in adults

EMA will assess the quality, safety and effectiveness data of molnupiravir. Credit: © 2009-2021 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.